Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 08, 2019

SELL
$17.38 - $26.88 $2.39 Million - $3.69 Million
-137,315 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$9.2 - $21.21 $279,017 - $643,256
30,328 Added 28.35%
137,315 $2.37 Million
Q4 2018

Feb 13, 2019

BUY
$9.61 - $14.02 $1.03 Million - $1.5 Million
106,987 New
106,987 $1.03 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $288M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.